Explained in plain English

Who pays for drug development?

Developing new drugs like solengepras is incredibly expensive, often costing billions. Pharmaceutical companies, such as US-based Cerevance, primarily fund this research and development. They invest heavily in trials and regulatory processes, hoping to recoup costs through sales once a drug is approved. This high cost often influences the price of new medications.